CSS
CAI

Cubist Systematic Strategies’s Caris Life Sciences CAI Stock Holding History

Cubist Systematic Strategies’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.14M Buy
70,731
+68,731
+3,437% +$2.19M 0.01% 1528
2025
Q2 		$53.4K Buy
+2,000
New +$53.9K ﹤0.01% 2778

Other funds holding CAI

SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Cubist Systematic Strategies's CAI Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Caris Life Sciences (CAI) stake by 3,437% in Q3 2025, buying an estimated $2.19M and bringing the position to 70,731 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #1528.

Cubist Systematic Strategies first reported a position in CAI in Q2 2025 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold CAI as of Q3 2025.

  • Cubist Systematic Strategies held 70,731 shares of Caris Life Sciences worth $2.14M as of Q3 2025.
  • Cubist Systematic Strategies bought 68,731 Caris Life Sciences shares in Q3 2025, an estimated $2.19M.
  • Caris Life Sciences made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1528 holding.
  • Cubist Systematic Strategies first reported a position in Caris Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.